Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
John H Noseworthy Insider Profile
4 Followers
John H Noseworthy, Director at Merck & Company, holds 5.56K shares in UnitedHealth (Ticker: UNH), holds 100.00 shares in Merck & Company (Ticker: MRK).
John H Noseworthy has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John H Noseworthy holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by John H Noseworthy
John H Noseworthy's Trading History
Merck & Company
May 30, 2017
Director
Uninformative Buy
―
$9.91K
UnitedHealth
Jan 06, 2025
Director
Uninformative Buy
―
$2.85M
List of latest transactions for each holding click on a transaction to see John H Noseworthy's performance on stock
You May Also Like
John H Noseworthy insider profile FAQ
What is the percentage of profitable transactions made by John H Noseworthy?
The percentage of profitable transactions made by John H Noseworthy is ―.
What is the average return per transaction made by John H Noseworthy?
The average return per transaction made by John H Noseworthy is ―.
What stocks does John H Noseworthy hold?
John H Noseworthy holds: MRK, UNH stocks.
What was John H Noseworthy’s latest transaction?
John H Noseworthy latest transaction was an Uninformative Buy of ―.
What was John H Noseworthy's most profitable transaction?
John H Noseworthy’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is John H Noseworthy's role in Merck & Company?
John H Noseworthy's role in Merck & Company is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.